TP53 and gastric neoplasm: It was discovered that those possessing the miR-34b/c rs4938723 CT/CC and TP53 CG/CC components displayed a 0.62-fold lesser chance to become afflicted by stomach cancer in comparison to people with miR-34b/c rs4938723 TT and TP53 CG/CC genotypes, implying that miR-34b/c rs4938723 could possibly stop the onset of gastric cancer [108].